Gilead Stock Gains. It's Trying to Get Into the Obesity Drug Game.
A success would be a gamechanger for the biotech company known for its HIV treatments.
Express News | IQVIA Holdings Inc : Baird Cuts Target Price to $241 From $245
Express News | IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?
A Closer Look At IQVIA Holdings Inc.'s (NYSE:IQV) Impressive ROE
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. We'll use ROE to e
Should You Be Impressed By IQVIA Holdings Inc.'s (NYSE:IQV) ROE?
AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said AbbVie Inc. (NYSE:ABBV) is a very solid pharmaceutical company. The company has good dividend yield and attractive valua
Express News | CNBC Halftime Report Final Trades: Amazon.Com, The Goldman Sachs Group, IQVIA Holdings, AbbVie
IQVIA Hldgs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/06/2024 23.34% Goldman Sachs → $270 Initiates Coverage On → Buy 05/03/2024 14.21% Evercore ISI Group $2
Goldman Sachs Initiates IQVIA Holdings(IQV.US) With Buy Rating, Announces Target Price $270
Goldman Sachs analyst Matthew Sykes initiates coverage on $IQVIA Holdings(IQV.US)$ with a buy rating, and sets the target price at $270.According to TipRanks data, the analyst has a success rate of 49
Goldman Sachs Initiates IQVIA With Buy Rating, $270 Price Target
IQVIA Holdings (IQV) has an average rating of outperform and price targets ranging from $245 to $295, according to analysts polled by Capital IQ.
(IQV) - Analyzing IQVIA Hldgs's Short Interest
IQVIA Hldgs's (NYSE:IQV) short percent of float has risen 3.83% since its last report. The company recently reported that it has 3.04 million shares sold short, which is 1.9% of all regular shares tha
Express News | NYSE Order Imbalance 75082.0 Shares on Buy Side
Sell Ideas in Staples and Health Care - Oppenheimer
Express News | NYSE Order Imbalance 337951.0 Shares on Sell Side
Those Who Invested in IQVIA Holdings (NYSE:IQV) Five Years Ago Are up 67%
IQVIA Holdings (IQV) Gets a Buy From Jefferies
Analysis-Weight-loss Drug Forecasts Jump to $150 Billion as Supply Grows
These 4 Measures Indicate That IQVIA Holdings (NYSE:IQV) Is Using Debt Reasonably Well
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvious that you need to consider debt, whe
IQVIA Holdings Insiders Sell US$10m Of Stock, Possibly Signalling Caution
No Data